Exploring Predictive Models in Neurology Clinical Data with Machine Learning

Abstract

Neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, multiple
sclerosis, and other neurodegenerative conditions continue to impose a significant burden on global
healthcare systems because of their increasing prevalence, progressive nature, and long-term disability
(Beam & Kohane, 2018; Bruffaerts, 2018). Accurate diagnosis and early prediction of disease
progression remain major clinical challenges since neurological disorders often involve heterogeneous
symptoms, complex pathological mechanisms, and multidimensional clinical data (Deo, 2015;
Rajkomar et al., 2019). Conventional statistical approaches and manual clinical assessment methods
frequently encounter limitations when processing large volumes of neurological information generated
from electronic health records, neuroimaging, laboratory investigations, genomic sequencing, wearable
sensors, and cognitive assessments (Jordan & Mitchell, 2015; Obermeyer & Emanuel, 2016). Machine
Learning (ML), a rapidly evolving branch of Artificial Intelligence (AI), has emerged as a
transformative technology for predictive analytics by enabling intelligent analysis of complex
neurological clinical datasets (Beam & Kohane, 2018; Ghassemi et al., 2021). Machine learning
algorithms automatically learn from historical patient information, recognize hidden relationships
among clinical variables, and develop predictive models capable of forecasting disease progression,
treatment response, hospitalization risk, and long-term patient outcomes (Miotto et al., 2018;
Steyerberg, 2019). These predictive capabilities enable clinicians to identify high-risk patients at earlier
stages, optimize treatment planning, and implement personalized therapeutic strategies that improve
neurological healthcare outcomes (Rajkomar et al., 2019; Myszczynska et al., 2020). Recent advances
in deep learning have further enhanced predictive performance by enabling automated interpretation of
neuroimaging obtained from magnetic resonance imaging (MRI), computed tomography (CT), positron
emission tomography (PET), and electroencephalography (EEG) systems (LeCun et al., 2015; Esteva
et al., 2019). Deep neural networks successfully identify subtle structural and functional abnormalities
associated with Alzheimer's disease, Parkinson's disease, epilepsy, and stroke while reducing diagnostic
variability and improving clinical consistency (Liu et al., 2019; Smith et al., 2023). The integration of
imaging data with electronic health records, genomic information, and laboratory investigations
significantly enhances prediction accuracy and supports precision neurology (Yu et al., 2018; Kernbach
& Staartjes, 2020). Machine learning also facilitates continuous patient monitoring through wearable
healthcare technologies that collect physiological measurements, gait characteristics, tremor intensity,
sleep behaviour, and movement patterns in real time (Sendak et al., 2020; Wiens & Shenoy, 2018).
Predictive analytics continuously evaluates these data streams to detect symptom deterioration, estimate
hospitalization risk, and generate early clinical alerts, thereby improving patient safety and treatment
effectiveness (Topol, 2019; Komorowski et al., 2018). Although challenges related to data privacy,
algorithm transparency, model interpretability, and ethical governance continue to influence widespread
implementation, predictive machine learning models demonstrate enormous potential for transforming
neurological diagnosis, prognosis, personalized medicine, and evidence-based clinical decision-making
(Ribeiro et al., 2016; Rudin, 2019).